EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)
Phase of Trial: Phase III
Latest Information Update: 23 Sep 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms EVOLVE II QCA
- 26 Oct 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.